Newshero

RECENT NEWS

For Media Inquiries

Alisa Santiesteban, Director of Marketing & Communications
970-926-1277 / Alisa@CanDo-MS.org

Media Kit


JUMPSTART® Program Coming to Reno, NV, on July 20

June 17th, 2019

Can Do Multiple Sclerosis is holding a free, one-day JUMPSTART® Program on Saturday, July 20, 2019, in Reno, NV. This educational and interactive program enables people with MS and their support partners to learn the knowledge, skills, and tools to adopt healthy lifestyle behaviors and actively co-manage their MS.

Continue Reading
JUMPSTART® Program Coming to New York, NY, on July 13

June 10th, 2019

Can Do Multiple Sclerosis is holding a free, one-day JUMPSTART® Program on Saturday, July 13, 2019, in New York, NY. This educational and interactive program enables people with MS and their support partners to learn the knowledge, skills, and tools to adopt healthy lifestyle behaviors and actively co-manage their MS.

Continue Reading
JUMPSTART® Program Coming to Charleston, WV, on June 22

May 20th, 2019

Can Do Multiple Sclerosis is holding a free, one-day JUMPSTART® Program on Saturday, June 22, in Charleston, WV. This educational and interactive program enables people with MS and their support partners to learn the knowledge, skills, and tools to adopt healthy lifestyle behaviors and actively co-manage their MS.

Continue Reading
JUMPSTART® Program Coming to Detroit, MI, on June 1

May 1st, 2019

Can Do Multiple Sclerosis is holding a free, one-day JUMPSTART® Program on Saturday, June 1, in Detroit, MI. This educational and interactive program enables people with MS and their support partners to learn the knowledge, skills, and tools to adopt healthy lifestyle behaviors and actively co-manage their MS.

Continue Reading
JUMPSTART® Program Coming to Nashville, TN on May 11

April 8th, 2019

Can Do Multiple Sclerosis is holding a free, one-day JUMPSTART® Program on Saturday, May 11, 2019, in Nashville, TN. This educational and interactive program enables people with MS and their support partners to learn the knowledge, skills, and tools to adopt healthy lifestyle behaviors and actively co-manage their MS.

Continue Reading
FDA approves new oral drug to treat multiple sclerosis

April 2nd, 2019

The U.S. Food and Drug Administration approved Mayzent (siponimod) tablets to treat adults with relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.

Continue Reading
FDA Approves MAVENCLAD® (Cladribine) Tablets as First and Only Short-Course Oral Treatment for Relapsing-Remitting and Active Secondary Progressive Multiple Sclerosis

April 2nd, 2019

EMD Serono announced that the U.S. Food and Drug Administration has approved MAVENCLAD® (cladribine) tablets for the treatment of adults with relapsing-remitting disease and active secondary progressive disease. 

Continue Reading
JUMPSTART® Program Coming to Tampa, FL on May 4

April 1st, 2019

Can Do Multiple Sclerosis is holding a free, one-day JUMPSTART® Program on Saturday, May 4, 2019, in Tampa, FL. This educational and interactive program enables people with MS and their support partners to learn the knowledge, skills, and tools to adopt healthy lifestyle behaviors and actively co-manage their MS.

Continue Reading
JUMPSTART® Program Coming to Little Rock, AR, on April 27

March 26th, 2019

Can Do Multiple Sclerosis is holding a free, one-day JUMPSTART® Program on Saturday, April 27, 2019, in Long Beach, CA. This educational and interactive program enables people with MS and their support partners to learn the knowledge, skills, and tools to adopt healthy lifestyle behaviors and actively co-manage their MS.

Continue Reading
JUMPSTART® Program Coming to Denver, CO, on April 13

March 11th, 2019

Can Do Multiple Sclerosis is holding a free, one-day JUMPSTART® Program on Saturday, April 13, 2019, in Denver, CO. This educational and interactive program enables people with MS and their support partners to learn the knowledge, skills, and tools to adopt healthy lifestyle behaviors and actively co-manage their MS.

Continue Reading